SCHEMBL29951776

SCHEMBL29951776

OB(O)c1cnc(Cl)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.41
TTR P02766 3/20 0.41
ALDH1A1 P00352 5/20 0.33
NPSR1 Q6W5P4 4/20 0.33
KMT2A Q03164 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340525 1.00 ENPP2 (0.41) ENPP2TTRALDH1A1NPSR1KMT2A
SCHEMBL25379067 0.80 TTR (0.39) ENPP2TTR
SCHEMBL29951314 0.78 CHRNB2 (0.33) ENPP2ALDH1A1
SCHEMBL29953155 0.78 PIK3CD (0.43) ENPP2TTRALDH1A1
SCHEMBL30858247 0.78 CHRNB2 (0.39) ENPP2TTR
SCHEMBL393995 0.78 CHRNB2 (0.33) ENPP2ALDH1A1
SCHEMBL16113231 0.78 CHRNB2 (0.39) ENPP2TTR
SCHEMBL14121768 0.78 KEAP1 (0.33) ENPP2TTR
SCHEMBL29955519 0.78 KEAP1 (0.33) ENPP2TTR
SCHEMBL16734509 0.78 PIK3CD (0.43) ENPP2TTRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478131-A 2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-07-25 CN disclosed
CN-116478132-A 2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-07-25 CN disclosed
CN-109983001-B 2, 5-disubstituted 3-methylpyrazines and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-04-04 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed